Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed attachment file name title grouped question UIN question first answered answering member label
tabling member	label

Search

1016224

	registered interest
	date	28/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Primary Health Care: Attendance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to address the effects of missed appointments on primary care services.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	196776
	answer	answer is ministerial correction date of answer 07/12/2018 answer text <p>We recognise that missed appointments are a waste of National Health Service resources. We believe that encouraging patients to use the NHS sensibly and responsibly is the right approach and we are supportive of local schemes to highlight the number of missed appointments to their patients. However, it is ultimately a matter for the local NHS and primary care providers to decide how best to raise awareness and implement measures to reduce missed appointments.</p><p> </p><p>Primary care providers are encouraged to offer patients different ways to book appointments, send appointment reminders by text messages, and make it quick for patients to cancel or re-arrange appointments e.g. through the use of an online service.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2018 13:02:06 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

1063955

	registered interest
	date	19/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Overseas Companies
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what proportion of GP practices are administered by healthcare companies based abroad.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	223127
	answer	answer is ministerial correction date of answer 26/02/2019 answer text <p>This information is not collected or held centrally.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 223130 question first answered 26/02/2019 15:35:55 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

1063958

	registered interest
	date	19/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Overseas Companies
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of GP consortia that are run for profit by overseas-based medical insurance firms.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	223130
	answer	answer is ministerial correction date of answer 26/02/2019 answer text <p>This information is not collected or held centrally.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 223127 question first answered 26/02/2019 15:35:55 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

1029362

	registered interest
	date	20/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Life Expectancy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of trends in life expectancy.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	204558
	answer	answer is ministerial correction date of answer 11/01/2019 answer text <p>Public Health England (PHE) was commissioned by the Department in 2018 to review trends in life expectancy and mortality in England. PHE’s review was released on 11 December 2018 and is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/recent-trends-in-mortality-in-england-review-and-data-packs" target="_blank">https://www.gov.uk/government/publications/recent-trends-in-mortality-in-england-review-and-data-packs</a></p><p> </p><p>The review summarises the findings from the commission and suggests further work that could be undertaken, by PHE or others. It provides a review of official data to advance understanding of the trends in life expectancy and mortality in England, as well as more detail on specific population groups and specific causes of death, including insight into possible explanations for the trends observed.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/01/2019 12:10:18 answering member 4067 label Biography information for Steve Brine
	tabling member	4471 label Biography information for Rachael Maskell

1029368

	registered interest
	date	20/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Labour Turnover
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent steps he has taken to improve the retention level of GPs within the NHS.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	204563
	answer	answer is ministerial correction date of answer 09/01/2019 answer text <p>NHS England and Health Education England (HEE) are working together with the profession to increase the general practitioner (GP) workforce. This includes measures to boost recruitment, address the reasons why GPs are leaving the profession, and encourage GPs to return to practice.</p><p> </p><p>There is a broad offer available to support GPs to remain in the National Health Service including the GP Health Service, the GP Retention Scheme, and the GP Retention Fund.</p><p> </p><p>In May 2018, NHS England launched the £10 million GP Retention Fund, comprising of the Local Retention Fund (£7 million) and the Intensive Support Areas (£3 million) which will help GPs stay in the workforce by promoting new ways of working and offering additional support.</p><p> </p><p>Recognising that workload is one of the biggest issues impacting retention, NHS England is investing £30 million in the Releasing Time for Care Programme, which aims to help practices reduce their workload through spreading awareness of innovations and facilitating local programmes.</p><p> </p><p>Getting the skills mix right in general practice is also critical in addressing workload pressures as well as in delivering appropriate patient care. This will mean bigger teams of staff, providing a wider range of care options for patients and freeing up more time for GPs to focus on those with more complex needs. As of September 2018, there were over 3,700 more clinical staff, excluding GPs, working in general practice since 2015; consisting of over 600 more nurses and over 3,000 more other direct patient care.</p><p> </p><p>In addition to this work, the General Practice Partnership Review, an independent review into the partnership model to which practices work, will deliver its final report early this year. The independent review will consider key questions around workforce and workload and make a number of recommendations with the aim of ensuring general practice remains an excellent place to work.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/01/2019 15:04:10 answering member 4067 label Biography information for Steve Brine
	tabling member	4471 label Biography information for Rachael Maskell

1029369

	registered interest
	date	20/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Visual Impairment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to tackle preventable blindness.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	204564
	answer	answer is ministerial correction date of answer 09/01/2019 answer text <p>The Government takes the concerns around reported avoidable sight loss very seriously. Following the All Party Parliamentary Group on Eye Health and Visual Impairment’s ‘See the Light’ report, initial meetings have been held with key stakeholders to discuss the Department and NHS England’s response to the report’s recommendations and these discussions are ongoing.</p><p> </p><p>Two key initiatives, Getting it Right First Time being led by NHS Improvement and the Elective Care Transformation Programme being led by NHS England have considered, as part of their programmes, what can be done to ensure patients do not suffer unnecessary delays in follow-up care for ophthalmology.</p><p> </p><p>Action is also being taken to reduce sight loss caused by medical conditions. On diabetic retinopathy, a common complication of diabetes which can lead to sight loss, a diabetic retinopathy screening programme led by Public Health England offered screening to 2.4 million eligible people in 2015/16.</p><p> </p><p>Early detection is also key and free National Health Service sight tests are available to those at increased risk of eye disease or likely to be deterred from seeking private tests on grounds of cost.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/01/2019 15:05:38 answering member 4067 label Biography information for Steve Brine
	tabling member	4471 label Biography information for Rachael Maskell

1029374

	registered interest
	date	20/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Babylon Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent meetings he has had with Babylon Healthcare.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	204568
	answer	answer is ministerial correction date of answer 11/01/2019 answer text <p>My Rt. hon. Friend the Secretary of State for Health and Social Care has met Babylon Healthcare on two occasions including at a technology roundtable attended by various health technology companies on 18 July 2018 and at their offices on 13 September 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/01/2019 12:07:13 answering member 4067 label Biography information for Steve Brine
	tabling member	4471 label Biography information for Rachael Maskell

1059803

	registered interest
	date	12/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Respiratory System: Staff
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he plans to collect data on the regional primary-care respiratory workforce in the NHS to address the long-term respiratory workforce challenge identified in the NHS Long Term Plan.
	tabling member constituency	Wythenshawe and Sale East
	tabling member printed	Mike Kane
	uin	220250
	answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>Following the publication of the NHS Long Term Plan, the National Implementation Framework, to be published in the spring, will provide further information on how the Long Term Plan will be implemented. Additional details, based on local health system five year plans, will be brought together in a detailed national implementation plan in the autumn.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/02/2019 17:23:56 answering member 4067 label Biography information for Steve Brine
	tabling member	4316 label Biography information for Mike Kane

1050071

	registered interest
	date	28/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dementia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to page 15 of the NHS Long Term Plan, published in January 2019, whether the revised GP Quality Outcomes Framework (QOF) proposed in that plan will effect QOF indicators for dementia including (a) new diagnoses, (b) care plans or memory assessment reviews and (c) named carers on records.
	tabling member constituency	Worsley and Eccles South
	tabling member printed	Barbara Keeley
	uin	213303
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>Major reform to the GP contract was announced at the NHS England Board meeting on 31 January 2019, which sets out significant investment in general practice, including a focus upon improving care to some of the most vulnerable patients through a multidisciplinary approach. Further information is available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/gp/gpfv/investment/gp-contract/" target="_blank">https://www.england.nhs.uk/gp/gpfv/investment/gp-contract/</a></p><p> </p><p>It also included changes to the Quality Outcomes Framework (QOF), reflecting the recommendations of the QOF Review published by NHS England in July 2018 is available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2018/07/quality-outcome-framework-report-of-the-review.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2018/07/quality-outcome-framework-report-of-the-review.pdf</a></p><p> </p><p>Key changes to the QOF include:</p><p>- The retirement of 28 indicators which are either no longer in line with National Institute for Health and Care Excellence guidance, suffer from known measurement problems (usually because of small numbers at a practice level) or represent core general practice activities (175 points);</p><p>- The introduction of 15 new indicators in relation to blood pressure management, diabetes, cervical screening, chronic obstructive pulmonary disease and mental health (101 points). These should lead to improvements in patient care and ultimately outcomes;</p><p>- The replacement of exception reporting with a personalised care adjustment which recognises the necessity for practices to be able to tailor care to individual patients; and</p><p>- The introduction of a quality improvement domain worth 74 points in 2019/20 and, in the first year, focused upon prescribing safety and end of life care.</p><p> </p><p>A number of further reviews of the QOF domains are planned, including that for mental health. In relation to dementia specifically, the current indicator DEM005 (pre-diagnosis blood tests) will be retired due to the small numbers at practice level. This decision is in line with the recommendations of the QOF review. There are no changes to the other two dementia care indicators which focus upon identification and care planning.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/02/2019 15:12:42 answering member 4067 label Biography information for Steve Brine
	tabling member	1588 label Biography information for Barbara Keeley

1050072

	registered interest
	date	28/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Preventive Medicine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to 63 of the NHS Long Term Plan, published in January 2019, what estimate he has made of the number of the target 150,000 cases of heart attack, stroke and dementia to be prevented that will be cases of (a) heart attacks, (b) strokes and (c) dementia; and whether any interim targets will be set over the ten year period of that plan.
	tabling member constituency	Worsley and Eccles South
	tabling member printed	Barbara Keeley
	uin	213304
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>Cardiovascular disease (CVD) prevention and management are key priorities for NHS England, and as such the NHS Long Term Plan contains details of a number of important measures in relation to CVD. A key milestone in the CVD section of the NHS Long Term Plan is that the National Health Service will help prevent up to 150,000 heart attacks, strokes and dementia cases over the next 10 years.</p><p> </p><p>The National Implementation Framework, to be published in the spring, will provide further information on how the NHS Long Term Plan will be implemented. Additional details, based on local health system five year plans, will be brought together in a detailed national implementation plan in the autumn.</p><p> </p><p>NHS England will continue to work closely with key partners and stakeholders, including the British Heart Foundation, Stroke Association, Alzheimer’s Society and other voluntary sector partners, as it supports the NHS to deliver the commitments set out in the NHS Long Term Plan.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/02/2019 15:22:49 answering member 4067 label Biography information for Steve Brine
	tabling member	1588 label Biography information for Barbara Keeley

1022885

	registered interest
	date	10/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Obesity
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will publish the number of people with obesity in (a) England and (b) each Clinical Commissioning Group area by (i) age and (ii) gender for each of the last five calendar years.
	tabling member constituency	Wolverhampton South West
	tabling member printed	Eleanor Smith
	uin	200681
	answer	answer is ministerial correction date of answer 18/12/2018 answer text <p>NHS Digital has advised that obesity data for children and adults in England by age and gender for each of the last five years is available in the Health Survey for England. This information is attached. Data is not available by clinical commissioning group.</p> answering member constituency Winchester answering member printed Steve Brine attachment 1 file name PQ200681 Adult obesity statistics.xlsx title PQ200681 attahced document 2 file name PQ200681 Child obesity statistics.xlsx title PQ200681 attahced document question first answered 18/12/2018 17:09:31 answering member 4067 label Biography information for Steve Brine
	tabling member	4609 label Biography information for Eleanor Smith

1022888

	registered interest
	date	10/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Obesity
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, which Clinical Commissioning Groups include weight management services on their list of procedures of limited clinical value.
	tabling member constituency	Wolverhampton South West
	tabling member printed	Eleanor Smith
	uin	200682
	answer	answer is ministerial correction date of answer 18/12/2018 answer text <p><strong></strong>The requested information is not held centrally. No assessment has been made of the effect on patients of clinical commissioning groups (CCGs) decommissioning tier 3 and tier 4 weight management services. CCGs have a statutory responsibility to commission services which meet the healthcare needs of their local population.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 200573 200574 200575 201217 question first answered 18/12/2018 17:11:57 answering member 4067 label Biography information for Steve Brine
	tabling member	4609 label Biography information for Eleanor Smith

1023177

	registered interest
	date	11/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Obesity
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on patients of the decommissioning of tier three and tier four weight management services by Clinical Commissioning Groups; and if he will make a statement.
	tabling member constituency	Wolverhampton South West
	tabling member printed	Eleanor Smith
	uin	201217
	answer	answer is ministerial correction date of answer 18/12/2018 answer text <p><strong></strong>The requested information is not held centrally. No assessment has been made of the effect on patients of clinical commissioning groups (CCGs) decommissioning tier 3 and tier 4 weight management services. CCGs have a statutory responsibility to commission services which meet the healthcare needs of their local population.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 200573 200574 200575 200682 question first answered 18/12/2018 17:11:57 answering member 4067 label Biography information for Steve Brine
	tabling member	4609 label Biography information for Eleanor Smith

1019454

	registered interest
	date	03/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Primary Health Care: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Government announcement of 21 November 2018 entitled New funding for primary and community healthcare by 2023-24 under the NHS Long Term Plan, how he plans to allocate the £3.5 billion of new funding up to 2023-24.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	198233
	answer	answer is ministerial correction date of answer 11/12/2018 answer text <p>On 21 November 2018, the Prime Minister announced investment in primary and community healthcare worth an additional £3.5 billion a year in real terms by 2023/4 and a commitment to ensure a growing share of overall National Health Service spending for primary medical and community healthcare.</p><p> </p><p>Allocation of the £3.5 billion of new funding is currently under consideration. The long-term plan is due to be published later this year with allocations for individual clinical commissioning groups expected to be determined early in the new year.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 198234 198235 question first answered 11/12/2018 16:45:00 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1019455

	registered interest
	date	03/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Primary Health Care: Essex
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Government announcement of 21 November 2018 entitled New funding for primary and community healthcare by 2023-24 under the NHS Long Term Plan, how much of that funding will be made available to (a) Mid-Essex Clinical Commissioning Group and (b) North East Essex Clinical Commissioning Group.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	198234
	answer	answer is ministerial correction date of answer 11/12/2018 answer text <p>On 21 November 2018, the Prime Minister announced investment in primary and community healthcare worth an additional £3.5 billion a year in real terms by 2023/4 and a commitment to ensure a growing share of overall National Health Service spending for primary medical and community healthcare.</p><p> </p><p>Allocation of the £3.5 billion of new funding is currently under consideration. The long-term plan is due to be published later this year with allocations for individual clinical commissioning groups expected to be determined early in the new year.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 198233 198235 question first answered 11/12/2018 16:45:00 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1019456

	registered interest
	date	03/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Centres: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Government announcement of 21 November 2018 entitled New funding for primary and community healthcare by 2023-24 under the NHS Long Term Plan, how much of that funding will be allocated to support the development of multi-disciplinary healthcare centres.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	198235
	answer	answer is ministerial correction date of answer 11/12/2018 answer text <p>On 21 November 2018, the Prime Minister announced investment in primary and community healthcare worth an additional £3.5 billion a year in real terms by 2023/4 and a commitment to ensure a growing share of overall National Health Service spending for primary medical and community healthcare.</p><p> </p><p>Allocation of the £3.5 billion of new funding is currently under consideration. The long-term plan is due to be published later this year with allocations for individual clinical commissioning groups expected to be determined early in the new year.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 198233 198234 question first answered 11/12/2018 16:45:00 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1019460

	registered interest
	date	03/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Essex
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many GP vacancies there are in (a) Witham constituency and (b) Essex.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	198239
	answer	answer is ministerial correction date of answer 11/12/2018 answer text <p>The number of general practitioner (GP) vacancies in Witham constituency and Essex is not collected or held centrally. This data is only published at a national level.</p><p> </p><p>Mid Essex Clinical Commissioning Group (CCG), has advised that it recognises that GP availability is challenging and it has therefore funded recruitment of other clinical roles in primary care, such as paramedics, to support practices in Witham and elsewhere.</p><p> </p><p>Getting the skills mix right in general practice is critical in addressing workload pressures as well as in delivering appropriate patient care. This will mean bigger teams of staff, providing a wider range of care options for patients and freeing up more time for GPs to focus on those with more complex needs. The CCG has advised that it is working with its member practices, including those in Witham, to reflect this national priority. Practices have the discretion within their contracts to decide the staff skill mix required to meet their patient populations’ needs.</p><p> </p><p>The CCG and colleagues across the Mid and South Essex Sustainability and Transformation Partnership have advised they are also focusing on European Union and international GP recruitment and are supporting GPs in accessing the GP retention scheme. They have also advised that they are supporting the development of the School of Medicine at Anglia Ruskin University and are working in partnership with the Essex Primary Care Inter-professional Centre around a localised clinical recruitment service called Essex Primary Care Careers.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 198240 question first answered 11/12/2018 16:46:17 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1019461

	registered interest
	date	03/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Essex
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the recruitment and retention of GPs in (a) Witham constituency and (b) Essex.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	198240
	answer	answer is ministerial correction date of answer 11/12/2018 answer text <p>The number of general practitioner (GP) vacancies in Witham constituency and Essex is not collected or held centrally. This data is only published at a national level.</p><p> </p><p>Mid Essex Clinical Commissioning Group (CCG), has advised that it recognises that GP availability is challenging and it has therefore funded recruitment of other clinical roles in primary care, such as paramedics, to support practices in Witham and elsewhere.</p><p> </p><p>Getting the skills mix right in general practice is critical in addressing workload pressures as well as in delivering appropriate patient care. This will mean bigger teams of staff, providing a wider range of care options for patients and freeing up more time for GPs to focus on those with more complex needs. The CCG has advised that it is working with its member practices, including those in Witham, to reflect this national priority. Practices have the discretion within their contracts to decide the staff skill mix required to meet their patient populations’ needs.</p><p> </p><p>The CCG and colleagues across the Mid and South Essex Sustainability and Transformation Partnership have advised they are also focusing on European Union and international GP recruitment and are supporting GPs in accessing the GP retention scheme. They have also advised that they are supporting the development of the School of Medicine at Anglia Ruskin University and are working in partnership with the Essex Primary Care Inter-professional Centre around a localised clinical recruitment service called Essex Primary Care Careers.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 198239 question first answered 11/12/2018 16:46:17 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1037967

	registered interest
	date	08/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	CJD
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve diagnosis rates of sporadic Creutzfeldt-Jakob disease.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206318
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206320 206323 206326 206327 question first answered 16/01/2019 15:05:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1037969

	registered interest
	date	08/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	CJD
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the symptoms of sporadic Creutzfeldt-Jakob disease are identified at the earliest opportunity.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206320
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206318 206323 206326 206327 question first answered 16/01/2019 15:05:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1037974

	registered interest
	date	08/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	CJD
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people were diagnosed with sporadic Creutzfeldt-Jakob Disease in (a) Witham constituency, (b) the East of England and (c) England and Wales in the most recent five years for which data is available.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206323
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206318 206320 206326 206327 question first answered 16/01/2019 15:05:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1037977

	registered interest
	date	08/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	CJD
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to raise awareness among medical professionals of the symptoms of (a) sporadic, (b) variant, (c) genetic and (d) Iatrogenic Creutzfeldt-Jakob Disease.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206326
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206318 206320 206323 206327 question first answered 16/01/2019 15:05:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1037985

	registered interest
	date	08/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	CJD
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the average waiting time has been for a diagnosis of sporadic Creutzfeldt-Jakob Disease (CJD) in the last five years for which data is available.
	tabling member constituency	Witham
	tabling member printed	Priti Patel
	uin	206327
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206318 206320 206323 206326 question first answered 16/01/2019 15:05:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4066 label Biography information for Priti Patel

1056741

	registered interest
	date	07/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Electronic Cigarettes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress he has made on implementing the recommendations accepted by the Government in its response to the Science and Technology Committee's Seventh Report of Session 2017-19 on E-cigarettes, HC505.
	tabling member constituency	Windsor
	tabling member printed	Adam Afriyie
	uin	218245
	answer	answer is ministerial correction date of answer 15/02/2019 answer text <p>The Government published its response to the Science and Technology Committee on the 10 December 2018. Good progress is being made on implementing the report’s recommendations: for example, Public Health England will publish its latest annual evidence review on e-cigarettes by the end of March 2019 and NHS England is developing guidance on e-cigarettes for mental health trusts. The Department will continue to monitor progress as part of its monitoring of the delivery of the Tobacco Control Plan for England.</p><p> </p><p>The Government believes in proportionate regulation of e-cigarettes, recognising that they are not risk-free. Through the European Union Tobacco Products Directive 2014/40/EU (TPD), transposed into United Kingdom law by the UK Tobacco and Related Products Regulations 2016 (TRPR), we have introduced measures to regulate e-cigarettes to reduce the risk of harm to children, protect against any risk of renormalisation of tobacco use, provide assurance on relative safety for users, and give businesses legal certainty. This has enabled the UK to implement appropriate standards for products whilst allowing smokers to move to e-cigarettes should they wish.</p><p> </p><p>While the UK Government is a member of the EU it will continue to comply with the requirements of the EU’s TPD. The Government has made a commitment to review the TRPR by May 2021 to consider its regulatory impact. In addition, as announced in the Tobacco Control Plan the Government will review where the UK’s exit from the EU offers us opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 218246 question first answered 15/02/2019 11:10:04 answering member 4067 label Biography information for Steve Brine
	tabling member	1586 label Biography information for Adam Afriyie

1056744

	registered interest
	date	07/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Electronic Cigarettes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Seventh Report of Session 2017-19 of the Science and Technology Committee on E-cigarettes, HC505, what steps he has taken to ensure that the regulatory system for e-cigarettes is risk-proportionate.
	tabling member constituency	Windsor
	tabling member printed	Adam Afriyie
	uin	218246
	answer	answer is ministerial correction date of answer 15/02/2019 answer text <p>The Government published its response to the Science and Technology Committee on the 10 December 2018. Good progress is being made on implementing the report’s recommendations: for example, Public Health England will publish its latest annual evidence review on e-cigarettes by the end of March 2019 and NHS England is developing guidance on e-cigarettes for mental health trusts. The Department will continue to monitor progress as part of its monitoring of the delivery of the Tobacco Control Plan for England.</p><p> </p><p>The Government believes in proportionate regulation of e-cigarettes, recognising that they are not risk-free. Through the European Union Tobacco Products Directive 2014/40/EU (TPD), transposed into United Kingdom law by the UK Tobacco and Related Products Regulations 2016 (TRPR), we have introduced measures to regulate e-cigarettes to reduce the risk of harm to children, protect against any risk of renormalisation of tobacco use, provide assurance on relative safety for users, and give businesses legal certainty. This has enabled the UK to implement appropriate standards for products whilst allowing smokers to move to e-cigarettes should they wish.</p><p> </p><p>While the UK Government is a member of the EU it will continue to comply with the requirements of the EU’s TPD. The Government has made a commitment to review the TRPR by May 2021 to consider its regulatory impact. In addition, as announced in the Tobacco Control Plan the Government will review where the UK’s exit from the EU offers us opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 218245 question first answered 15/02/2019 11:10:04 answering member 4067 label Biography information for Steve Brine
	tabling member	1586 label Biography information for Adam Afriyie